Global Renal Denervation Market 2016-2020

Market outlook of global renal denervation

Technavio’s market research analyst predicts the global renal denervation (RD) market to account for a CAGR of almost 12% during the forecast period. One of the primary drivers for the growth of the market is the growing prevalence of hypertension. Unhealthy dietary habits, stress, and lack of physical exercise due to hectic lifestyles are common risk factors for hypertension, hypercholesterolemia, coronary heart diseases, and diabetes. Following the increased prevalence of hypertension among people, the demand for RD procedures has also increased, thereby, leading to the growth of the renal denervation market.

The adoption of minimally invasive catheter-based endovascular procedure is another major factor leading to the renal denervation market growth. Minimally invasive and localized nature procedure has increased the adoption of renal denervation devices as these devices are safe, effective, and reduce cardiometabolic risk. Additionally, the recent expansion of minimally invasive endovascular procedures had led to the development of a radio-frequency catheter-based approach for renal denervation.

Geographical segmentation and analysis of the renal denervation market

• Europe
• Rest of the world

Based on the renal denervation industry insights, Europe was the biggest market for renal denervation and accounted for a share of more than 57% of the overall market in 2015. Countries such as Germany, France, the UK, and Italy in Europe were the largest revenue contributors in the global renal denervation devices market. Some of the major factors supporting the growth of the market are the increase in the number of cases of drug-resistant hypertension and technological advancements.

Competitive landscape and key vendors

The vendors in the renal denervation market are developing technological advancements through each clinical trials, thus resulting in immense growth potential for the market. The high competition in the market is leading to an increasing number of M&A in the market; wherein small enterprises are acquired by international and leading vendors.

The leading vendors in the market are 

• Boston Scientific
• Medtronic
• ReCor Medical
• St. Jude Medical

Other prominent vendors in the market include Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.

Growth drivers, challenges, and upcoming trends - Renal denervation

Technavio’s market research analysts accentuate upcoming renal denervation market trends such as the high adoption of radio-frequency technology, which is stimulating the growth of the market. Despite the risk involved during the use of high-frequency radiation for medical therapy, research studies have proved it to be effective and safe if used cautiously.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the global renal denervation market. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Key questions answered in this report

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global renal denervation market?
• What are the key market trends impacting the growth of the global renal denervation market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the vendors in the global renal denervation market?
• What are the trending factors influencing the market shares of Europe and ROW?
• What are the key outcomes of the five forces analysis of the global renal denervation market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global Minimal Invasive Surgery Market 2015-2019
• Global Radiofrequency Ablation Devices Market 2015-2019
• Medical Technologies Market in the APAC Region 2015-2019